• NewAmsterdam Pharma (NASDAQ:NAMS) Given Average Rating of "Buy" by Analysts

    Source: Buzz FX / 26 Dec 2024 05:26:13   America/New_York


    NewAmsterdam Pharma (NASDAQ:NAMS) Given Average Rating of "Buy" by Analysts Written by MarketBeat December 26, 2024 Share Link copied to clipboard. NewAmsterdam Pharma ( NASDAQ:NAMS - Get Free Report ) has received a consensus recommendatio
    Read more...
Share on,